Pluripotent Stem Cells are a type of stem cell with the remarkable ability to differentiate into various cell types of the three germ layers: ectoderm, mesoderm, and endoderm. These cells hold immense potential in regenerative medicine and developmental biology due to their capacity to give rise to almost any cell in the human body. Embryonic stem cells, derived from the inner cell mass of blastocysts, are considered pluripotent as they can differentiate into all cell types. Induced pluripotent stem cells (iPSCs) are another source, generated by reprogramming adult cells to regain pluripotency through the introduction of specific transcription factors. Pluripotent stem cells have the ability to self-renew indefinitely, maintaining their undifferentiated state through controlled cell division. This unique property makes them valuable for research and therapeutic applications. Research involving pluripotent stem cells aims to understand the molecular mechanisms governing pluripotency and differentiation. This knowledge is crucial for harnessing the potential of these cells in regenerative medicine, such as tissue repair and replacement therapies. The ethical considerations associated with the use of embryonic stem cells have led to increased interest in iPSCs as an alternative, as they can be generated without the need for embryonic tissue. Pluripotent stem cells have shown promise in treating various diseases and conditions, including neurodegenerative disorders, heart disease, and spinal cord injuries. Their ability to differentiate into specific cell types allows for the development of patient-specific cells for transplantation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States